IoT Software Infrastructure for Remote Monitoring of Patients with Chronic Metabolic Disorders by Patti, Edoardo et al.
04 August 2020
POLITECNICO DI TORINO
Repository ISTITUZIONALE
IoT Software Infrastructure for Remote Monitoring of Patients with Chronic Metabolic Disorders / Patti, Edoardo;
Donatelli, Maria; Macii, Enrico; Acquaviva, Andrea. - (2018), pp. 311-317. ((Intervento presentato al convegno The IEEE
6th International Conference on Future Internet of Things and Cloud (FiCloud 2018) tenutosi a Barcelona, Spain nel 6-8
August 2018.
Original
IoT Software Infrastructure for Remote Monitoring of Patients with Chronic Metabolic Disorders
ieee
Publisher:
Published
DOI:10.1109/FiCloud.2018.00052
Terms of use:
openAccess
Publisher copyright
copyright 20xx IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other
uses, in any current or future media, including reprinting/republishing this material for advertising or promotional
purposes, creating .
(Article begins on next page)
This article is made available under terms and conditions as specified in the  corresponding bibliographic description in
the repository
Availability:
This version is available at: 11583/2711997 since: 2018-10-31T15:55:29Z
IEEE
IoT Software Infrastructure for Remote Monitoring
of Patients with Chronic Metabolic Disorders
Edoardo Patti∗, Maria Donatelli‡, Enrico Macii§ and Andrea Acquaviva§
∗Dept. of Control and Computer Engineering, Politecnico di Torino, Torino, Italy
‡ Biomedical Dept. of Internal and Specialistic Medicine, University of Palermo, Palermo, Italy
§Interuniversity Dept. of Regional and Urban Studies and Planning, Politecnico di Torino, Torino, Italy
{edoardo.patti, enrico.macii, andrea.acquaviva}@polito.it, {maria.donatelli}@unipa.it
Abstract—Novel Information and Communication Technolo-
gies, such as Internet-of-Things (IoT), middleware and cloud
computing, are providing innovative solutions ranging in different
contexts. Smart health is one of these scenarios. Indeed, there is
a rising interest in developing new healthcare services for remote
patient assistance and monitoring. Among all, the main promised
benefits consist on improving the patients’ quality of life, speeding
up therapeutic interventions and reducing hospitalizations’ costs.
This is also known as Telemedicine. In this paper, we present a
novel distributed software infrastructure for remote monitoring
of patients with chronic metabolic disorders: i) it collects and
and makes available information coming from IoT devices, ii) it
performs analysis to help medical diagnosis and iii) it promotes
a bidirectional communication among the end-users (i.e. medical
personnel and patients). In this paper, we also present our
experimental results performed in a laboratory test environment
to validate the proposed solution.
Index Terms—Internet of Things, Distributed software infras-
tructure, Cloud, Smart Health, Telemedicine, Remote healthcare
I. INTRODUCTION
In the last decades, we are witnessing to a demographic
change characterized by a progressive lengthening of life
expectancy and an increase in the elderly population. This is
leading to an exponential growth of chronic metabolic disor-
ders. In Europe, the percentage of over-65 raised from 14.6%
in 1990 to 17.2% in 2005 and it is expected to be around
20.7% in 2020 [1]. In Italy, the percentage of over-65 exceeded
the 22.3% in 2016 and around 88% of over-75 citizens is
affected at least by a chronic pathology [2]. This lengthening
of life expectancy implies an increase in healthcare spending
and the inefficient management of resources (e.g. medical
personnel, hospitals and technologies). In this scenario, the in-
creasing demand of healthcare leads to rethink and change the
organization of services that must be decentralized promoting
solutions for remote assistance, also known as Telemedicine.
The World Health Organization (WHO) defines Telemedicine
as follows: ”The delivery of healthcare services, where dis-
tance is a critical factor, by all healthcare professionals using
Information and Communication Technologies (ICT) for the
exchange of valid information for diagnosis, treatment and
prevention of disease and injuries, research and evaluation,
and for the continuing education of healthcare providers, all
in the interests of advancing the health of individuals and their
communities” [3], [4]. This highlights that Telemedicine and
remote healthcare services are extremely useful for patients
with stable chronic pathologies. Indeed, they allow medical
personnel on having updated medical records for their patients
avoiding unnecessary hospital admissions. The benefits of
these decentralized healthcare services can be summarized as
follows:
• improvement of patients’ quality of life;
• speed up therapeutic interventions to solve serious
metabolic disorders;
• increase patients’ awareness on their illness;
• adapt therapies to patients daily life;
• improvement of the quality of the healthcare services;
• reduction of access to the emergency room for erroneous
therapies or for therapies not adapted to changes in
patients’ medical records;
• reduction of hospitalizations and their costs;
• positive impact of patients on new e-health technologies.
In this view, novel ICT solutions are crucial to foster remote
patient monitoring and healthcare services. Key rising tech-
nologies to move forwards along this direction are i) Internet-
of-Things (IoT), ii) middleware and iii) cloud computing [5].
On these premises, we present a novel distributed software
infrastructure, a.k.a. HEALTHIOT, for remote monitoring of
patients with chronic metabolic disorders. In this paper, we
focused on two types of patients: patients with diabetes disease
(type 1 or type 2 diabetes) and patients undergoing house
dialysis. However, we designed and developed HEALTHIOT to
be extended taking into account also other medical patholo-
gies. Thus, new healthcare services, post-process and applica-
tions can be developed following the needs of both medical
personnel and patients. The proposed platform makes avail-
able i) vital patient’s parameters to doctors in near-real-time
and ii) post-processed information to help in doing medical
diagnosis. In addition, HEALTHIOT promotes a bidirectional
communication and information exchange i) between patients
and their doctors and ii) among different experts and specialists
(if authorized).
The rest of this paper is organized as follows. Section II
reviews most relevant literature solutions. Section III intro-
duces the proposed IoT software infrastructure for remote
patients’ monitoring. Section IV presents the laboratory tests
we performed to validate proposed solution. Finally, Section V
discusses concluding remarks and future works.
II. RELATED WORK
Nowadays, rising ICT solutions are becoming key players
to foster novel services for different context, such as Smart
City, Smart Energy and Smart Health. As pointed out by [5],
the Internet-of-Things, together with middleware technologies
and cloud computing, is crucial to design and develop such
new tools, platforms and applications, especially in the context
of Smart Health and/or Telemedicine.
Fan et al. [6] proposed a smart rehabilitation systems based
on IoT devices. The core of the system is an Ontology to
help doctors i) in making quick diagnosis of patients and
ii) in creating automatically a rehabilitation strategy based
on the specific requirements of patients. Then, IoT devices
are used to provide immediate information. VIRTUS [7] is an
event-driven middleware that builds a multi-layered software
architecture. It enables the interoperability among different
devices and applications through XMPP protocol. In the
context of Smart Health, VIRTUS has been used to implement
a remote rehabilitation systems as case-study. UDA-IoT [8]
is a cloud-based platform designed to collect and process
information coming from IoT devices. It aims at sharing such
ubiquitous information to improve the emergency medical
services. In [9], authors present both a Smart e-Health Gateway
for heterogeneous IoT sensors integration and a reference
architecture for healthcare services. This architecture follows a
fog computing approach where the intelligence is distributed
among Smart e-Health Gateways that form an intermediary
layer between IoT devices and the Cloud layer. Abawajy et
al. [10] present a remote pervasive patient health monitoring
framework. It combines both IoT devices and cloud computing
to remote monitor health conditions of patients in real-time.
Finally, iHealth [11] is a company that provides commercial
IoT devices that send patient’s vital parameters to its cloud,
usually through a mobile phone. However, this cloud is limited
in integrating only iHealth devices and it does not provide tools
to post-process collected information.
The presented solutions are mainly focused on addressing a
specific healthcare service. In addition, they lack on providing
specific tools or modules to analyse and post-process patient’s
information for helping doctors in making medical diagno-
sis. Whilst, in our view an IoT platform for Smart Health
and/or Telemedice should be customizable and extendible to
provide general purpose healthcare services, hence to address
different pathologies. In this view, we propose HEALTHIOT,
a distributed software infrastructure for remote monitoring of
patients with chronic metabolic disorders. It is a cloud-based
infrastructure that i) integrates heterogeneous off-the-shelf IoT
devices; ii) provides medical personnel with vital patient’s
parameters in near-real-time; iii) helps in making patients’
diagnosis; iv) allows a bidirectional data exchange between
patients and medical personnel. In this paper, we present
healthcare services for two classes of patients: i) patients with
diabetes disease (type 1 or type 2 diabetes) and ii) patients
undergoing house dialysis. Such services have been developed
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Fig. 1. Scheme of HEALTHIOT software infrastructure.
following the requirements given by both diabetologists and
nephrologists. However, HEALTHIOT is an open infrastructure
that provides unified API and Web Services allowing the
development of general purpose healthcare services. Hence,
further services and applications can be developed for other
pathologies and metabolic disorders.
III. SOFTWARE INFRASTRUCTURE FOR REMOTE PATIENTS’
MONITORING
In this section, we present HEALTHIOT, our IoT software
infrastructure for remote patients’ monitoring. Its core has
been developed starting from SiteWhere platform [12], which
has been extended to address Telemedicine and remote health-
care objectives. HEALTHIOT allows a bidirectional commu-
nication and information exchange i) between patients and
their doctors and ii) among different experts and specialists
(if authorized). It has been designed to integrate heteroge-
neous IoT devices for healthcare monitoring by abstracting
different underlying low-level technologies. It also enables
the interoperability among such heterogeneous devices and
offers a common data access to patients information. HEALTH-
IOT already integrates different technologies and protocols
(e.g. IEEE 802.11 and Bluetooth) adopted by novel off-the-
shelf IoT devices. Moreover, HEALTHIOT has been designed
exploiting a microservice approach [13], [14] allowing the
deployment on cluster of servers or in cloud systems. In
addition, HEALTHIOT supports the multi-tenancy [15]. A
tenant refers to a group of customers with shared common
access and privileges to software instance. Multi-tenant soft-
ware is a single instance of software that serves various
tenants by providing a dedicated share of the same software
instance avoiding data intermingling among different tenants.
HEALTHIOT multi-tenancy also allows separating data storage
and processing pipelines.
As shown in Figure 1, HEALTHIOT consists of four lay-
ers: i) Technology Integration Layer, ii) Middleware Layer,
iii) Services Layer and iv) Application Layer. The rest of this
section describes each layer in more detail.
A. Technology Integration Layer
The Technology Integration Layer, the lowest in Figure 1,
is in charge of integrating heterogeneous IoT technologies
through Technology Integration Adapters (TIAs). TIA is a
software component that abstracts features and functionalities
of IoT devices following a methodology proposed in [16].
It acts as a bridge between HEALTHIOT and the underlying
technology translating whatever kind of language the low-
level technology speaks (e.g. IEEE 802.11 and Bluetooth) into
common web interfaces. This is a crucial component because
it allows to use each low-level technology transparently. In
particular, we developed a TIA to integrate the iHealth [11]
cloud, consequently all the iHealth IoT devices (i.e. activity
trakers, smart scales, pulse oximeters, blood pressure moni-
tors and glucometers), and another TIA for the glucometers
produced by Menarini group [17].
B. Middleware Layer
The Middleware Layer is the core of HEALTHIOT. As
shown in Figure 1, it consists of different components:
i) to enable and guarantee a bidirectional communication
with IoT devices through TIAs; ii) to store information and
iii) to provide unified interfaces to access data and devices.
The whole HEALTHIOT exploits the two main communica-
tion paradigms for information exchange: i) request/response
and ii) publish/subscribe [18]. Request/response enables syn-
chronous communication through REST web services [19].
Publish/subscribe allows asynchronous communication that
complements request/response. It enables the development of
scalable loosely-coupled event-based systems, services and ap-
plications that can react in (near-) real-time. In HEALTHIOT,
we adopted the MQTT protocol [20]. In this view, the Message
Broker (see Figure 1) manages the MQTT communication.
It also routes all messages to the Communication Engine
that manages the communication between HEALTHIOT and
the IoT devices. In its core, the Communication Engine
consists of four sub-modules: i) Event Sources, ii) Inbound
Pipeline, iii) Outbound Pipeline and iv) Command Desti-
nations. The Event Sources module receives measurements
and alerts from devices (through TIAs) and checks message
integrity before forwarding them to the Inbound Pipeline.
The Inbound Pipeline module implements smart buffers to
avoid data transmission spikes and congestions in storing
information into the Data Storage. Similarly, both Outbound
Pipeline and Command Destinations modules handles out-
coming messages that have to be sent to IoT devices through
MQTT. Hence, HEALTHIOT is ready to send commands back
to IoT devices if required by applications and services. The
Data Storage integrates different non-relational database mod-
els (e.g. document oriented or time series), where information
are stored. The Device Management registers new IoT devices
and the Asset Manager handles information of the assets (e.g.
patients, doctors, places and things) and their associations. The
REST API Interface Manager provides REST web services to
applications and services for accessing data in HEALTHIOT.
To access information and to verify permissions in performing
certain operations, HEALTHIOT authenticates both services
and users.
C. Services Layer
The Services Layer has a dual role: i) on the one hand, it
provides modules to post-process patient’s information; ii) on
the other hand, it is the back-end for the HEALTHIOT’s
applications.
The Disease Manager is a sort of virtual box where different
post-processing rules are executed as independent microser-
vices. These rules analyse the healthcare information coming
from IoT devices and provide output in terms of messages
to be sent either to doctors or patients. Such rules and their
parameters can be personalized and contextualized by doctors
according to personal medical records of each patient. More
details about the developed post-processing rules are given in
Section IV. User Registration Service deals with both regis-
tration of users (either doctor or patient) and their access to
the platform. Patient Services and Patient Monitoring Services
consist of a set microservices to manage data exchange and
data correlation of the applications for patients and doctors,
respectively.
D. Application Layer
The Application Layer, the higher in Figure 1, offers API
(Application Programming Interfaces) to develop novel appli-
cations for managing and accessing information coming from
the underlying HEALTHIOT’s layers. We developed specific
applications for both patients and doctors. Diary App is a
digital diary to report daily results of treatment and therapy.
Thus, paper-based information is digitalized to foster remote
patients’ monitoring and to speed-up the information exchange
among patients and doctors. For example, patients with renal
insufficiency have to daily record the results of house dialysis
and provide a complete report on it, usually, every 2 or
3 weeks. With Diary App, the daily report is immediately
notified to doctors as soon as the patient fill it. Smart Glucose
is an app for patients with diabetes disease i) to visualize trends
of glucose and ketones in the blood over the time and ii) to
provide possible messages from the doctor or from the system.
Patient Monitoring is a mobile app suitable for Android-
based tablets. It provides doctors with the medical record of
their patients. This information is updated in (near-) real-time
and comes from IoT devices, services or other applications
(i.e. measurements, post-processed information and warnings).
This allows a continuous remote monitoring and assistance of
patients from both treatment and therapy viewpoints.
It is worth noting that the whole HEALTHIOT platform
is opened on developing other novel applications, services
and post-processing rules according to needs of both medical
personnel and patients. HEALTHIOT is also ready to host
machine learning algorithms to analyse patient health trends.
Thus, it is not limited on those presented in this section.
IV. EXPERIMENTAL RESULTS
In this section, we describe the laboratory tests we per-
formed to validate the HEALTHIOT platform and its services.
For this purpose, we developed a special TIA that emulates
different realistic patient conditions by injecting data in the
platform. Every time a new data is received by HEALTHIOT,
such information is post-processed by rules running on Dis-
ease Manager. The requirements of these rules come from the
interviews we did to various doctors, both diabetologists and
nephrologists. In the following, we describe each implemented
rule and we discuss their experimental results. Each rule
provides warnings as result of the computation. A warning is a
message that is sent from the platform to the end-users, either
patients or doctors. These warning messages help doctors in
doing their medical diagnosis that can lead to further medical
analysis or patient’s hospitalization.
1) Variation of Body Mass Index rule: In general, main-
taining a target weight is a good health habit for everyone.
In particular, weight control for patients with diabetes disease
and patients undergoing dialysis is crucial because most of
them can also be affected by diseases related to body weight.
Variation of Body Mass Index is a rule that analyses the Body
Mass Index (BMI) trend of a patient. BMI results from the
correlation of mass (weight) and height of a patient [21]. It
is defined as the body mass divided by the square of the
body height and it is expressed as kg/m2. BMI quantifies the
amount of tissue mass (muscle, fat and bone) and categorizes
that person as underweight, normal weight, overweight or
obese according to BMI ranges in Table I. Figure 2 shows the
BMI trend of our emulated patient and the generated warnings
for 90 days (one sample per day). In this case, the BMI of
the emulated patient constantly decreases from 38kg/m2 to
18kg/m2 and the rule generates the right warnings according
to BMI values. Only between day 58 and day 87, no warnings
are generated because it is a normal weight condition.
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Fig. 2. BMI trend variation and generated warnings.
TABLE I
BMI RANGES FOR PATIENT CLASSIFICATION.
Classification BMI ranges
Underweight 16 kg/m2 ≤ BMI < 18.5 kg/m2
Normal weight 18.5 kg/m2 ≤ BMI < 25 kg/m2
Overweight 25 kg/m2 ≤ BMI < 30 kg/m2
Obese 30 kg/m2 ≤ BMI ≤ 40 kg/m2
2) Anomalous variation of body weight rule: The variation
(increase or decrease) of weight in a short time period is
to be considered an alarming condition. Anomalous variation
of body weight (∆w) is a rule that compares the last body
weight sample with previous values belonging to a pre-defined
observation interval (SW), which is a sliding window. Figure 3
shows the body weight trend of our emulated patient and
the generated warnings for 40 days (one sample per day).
In this case, the rule generates a warning if ∆w ≤ 8 kg
or ∆w ≥ 8 kg for an observation interval in the range of
the previous 7 days and the previous 14 days. As shown in
Figure 3, the body weight of the emulated patient is almost
constant at 52kg for the first 9 days. Then, it constantly
increases for the next 9 days reaching 61kg. This generates
the first type of warnings, anomalous increase of weight
(red line), at day 18 by considering the information on the
observation interval SW-1 (red dashed-line box in Figure 3).
Then, the weight is almost constant at 61kg for few days
before decreasing to 55kg at day 29. This triggers the second
type of warnings, anomalous decrease of weight (violet line),
based on the observation interval SW-2 (violet dashed-line
box in Figure 3). This rule is very important because can
help doctors in understanding how a new therapy impacts
on the patient’s metabolism and thus intervening promptly by
modifying the therapy before the clinical conditions become
critical.
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Fig. 3. Body weight trend variation and generated warnings.
3) Blood pressure warning rule: Hypertension is a clinical
condition that often affects patients, especially older, with
type 2 diabetes. Hence, Blood pressure warning rule analyses
the incoming measurements on both systolic and diastolic
pressure (SBP and DBP, respectively). It generates warning
messages as soon as SBP is higher than 150mmHg or DBP
is higher than 95mmHg. Figure 4 shows a cloud of blood
pressure measurements for our emulated patient. It confirms
that warnings are generated only when measurements are over
the defined thresholds (red triangles in Figure 4).
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Fig. 4. Blood pressure and Hypertension warnings.
4) Blood pressure and oxygenation warning rule: This rule
has been implemented to monitor patients undergoing dialysis.
It generates a warning when the patient is in one of the
following conditions: i) Hypoxaemia and Hypertension or
ii) Hypoxaemia and Hypotension. Hypoxaemia occurs when
the blood oxygenation is lower than 94%. Hypotension condi-
tion takes place when SBP or DBP are lower than 100mmHg
or 70mmHg, respectively. Finally for this class of patients,
nephrologists suggested to consider Hypertension when SBP
and DBP are higher than 160mmHg or 100mmHg, respec-
tively. To be correlated, measurements must be sampled in the
same short time period, which must not be over the six hours.
Figure 5 shows a 3D representation of the resulting warnings
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Fig. 5. Blood pressure and oxygenation warnings (3D representation).
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(red triangles) for our emulated patient. Figure 6 and Figure 7
are two other representations of these results highlighting that
warnings are generated only if correlated data are out of the
given thresholds for blood oxygenation (Figure 6) and blood
pressure (Figure 7).
5) Glycaemia warning rule: Analysing the blood glucose
level (i.e. glycaemia) is also crucial for our patients, especially
for those affected by diabetes. We can distinguish between
two pathological conditions: i) severe Hyperglycaemia when
glycaemia is higher than 250mg/dl and ii) Hypoglycaemia
when glycaemia is lower than 70mg/dl. It is worth noting
that a severe Hyperglycaemia condition allows doctors in re-
questing an immediate patient’s hospitalization. This has been
implemented as the Glycaemia warning rule. Figure 8 plots a
cloud of glycaemia measurements of our emulated patient for
almost 6 months (one sample per day). As expected among
the total 170 samplings, only 39 of them generate warnings:
27 for severe Hyperglycaemia conditions (violet triangles on
top of the plot) and 12 for Hypoglycaemia conditions (red
triangles on bottom of the plot).
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6) Diabetic Ketoacidosis warning rule: The Diabetic Ke-
toacidosis is a very serious pathological condition that occurs
mainly in patients with type 1 diabetes. This condition allows
doctors in requesting an immediate patient’s hospitalization.
It is characterized by Hyperglycaemia and Hyperchetonemia.
Dehydration is also an indicator of this condition. It is an effect
of the Diabetic Ketoacidosis and not a cause. Thus, incoming
information on dehydration is a trigger to control glycaemia
and ketones, which will eventually generate warning messages.
The developed Diabetic Ketoacidosis warning rule correlates
information coming from glucometers (i.e. glycaemia and
ketones) and from smart scales (i.e. total body water). To
be correlated, measurements must be sampled in the same
time period, which must not be over the two hours. To
generate a warning, the rule considers: i) glycaemia higher
than 250mg/dl (severe Hyperglycaemia), ii) ketones higher
than 1.6mmol/l (Hyperchetonemia) and iii) total body wa-
ter lower than 45% (Dehydration). Figure 9 and Figure 10
show the results of this rule for our emulated patient. Both
figures highlight two type of warnings: i) warnings generated
by Hyperglycaemia, Hyperchetonemia and Dehydration (red
triangles), ii) warnings due to Hyperglycaemia and Hyper-
chetonemia (green triangles). Figure 10 omits the values of
total body water confirming that Dehydration is an effect of
the Diabetic Ketoacidosis as pointed by doctors during the
interviews.
7) Glycaemia averaged trend rule: This rule analyses the
glycaemia trend of patients undergoing dialysis. For each
incoming glycaemia measurement, the rule retrieves all the
previous samples received in the last 30 days from the Data
Storage (see Section III) and averages them together with
the new value. A warning is triggered if this average is over
120mg/dl. This condition is a trigger for doctors to request
more accurate medical analysis. For example, in case of fasting
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blood glucose higher than 120mg/dl, the patient could also be
affected by diabetes disease. Figure 11 shows the glycaemia
trend (blue line) of our emulated patient and the post-processed
average (green line) for almost 90 days. It confirms that the
rule generates a warning only if the averaged glycaemia exceed
the given threshold. This correctly occurred twice: i) between
day 31 and day 50 and ii) between day 73 and day 77.
V. CONCLUSION
In this paper, we presented HEALTHIOT, a novel distributed
software infrastructure for remote monitoring of i) patients
with diabetes disease (type 1 or type 2 diabetes) and ii) patients
undergoing house dialysis. It integrates different off-the-shelf
IoT devices for healthcare monitoring and performs analysis
on patient’s health conditions. To perform such analysis,
HEALTHIOT includes in its core a Disease Manager, which
executes and orchestrates different post-processing rules. Such
rules have been developed following the requirements given
by doctors (both diabetologists and nephrologists) and they are
customizable according to personal medical records of each
patient. HEALTHIOT is also opened for future developments of
new services, rules and end-user applications. In this paper, we
also discussed the preliminary results to validate the proposed
solution in a laboratory test environment.
As future work, we plan to extend the HEALTHIOT to
other clinical pathologies and to perform tests in a real-world
environment by involving real patients and doctors.
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